Article Details
Retrieved on: 2022-03-11 03:37:13
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The company's third proprietary technology platform, extended release TriTAC-XR, is designed to mitigate cytokine release syndrome.
Article found on: www.bakersfield.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here